Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

This program funds revision applications from currently funded NCI R01 projects to adapt and clinically validate existing biomarkers or assays for cancer detection, diagnosis, prognosis, monitoring, prediction of treatment response, prevention, or control. It does not fund early technology development or clinical trials, and applications must not propose clinical trials. Eligible applicants include many U.S. and foreign organizations, including nonprofits, universities, governments, for-profits, small businesses, and foreign organizations. The application budget is limited to $150,000 in direct costs in any single year, the maximum project period is 3 years, and the parent R01 must have at least two years of support remaining at the estimated time of award. No cost sharing is required.

✳ AI-generated summary — verify against the announcement

• Education
• Health
• Research & Discovery
• Researchers & Scholars
• Biomedical & Disease Research

• ✓ City or township governments
• ✓ County governments
• ✓ For-profit organizations other than small businesses
• ✓ Independent school districts
• ✓ Native American tribal governments (Federally recognized)
• ✓ Native American tribal organizations (other than Federally recognized)
• ✓ Nonprofits with 501(c)(3) status (other than higher education)
• ✓ Nonprofits without 501(c)(3) status (other than higher education)
• ✓ Others
• ✓ Private institutions of higher education
• ✓ Public and State controlled institutions of higher education
• ✓ Public housing authorities / Indian housing authorities
• ✓ Small businesses
• ✓ Special district governments
• ✓ State governments